Viewing Study NCT01200992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:49 PM
Ignite Modification Date: 2026-02-01 @ 10:00 AM
Study NCT ID: NCT01200992
Status: TERMINATED
Last Update Posted: 2017-08-24
First Post: 2010-09-12
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Sponsor: Bioniche Life Sciences Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Neoplasm View
None Neoplasm Recurrence, Local View
None Transitional Cell, Carcinoma View
None Carcinoma in Situ View
None Mycobacterium View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Urinary Bladder Neoplasms View
None Neoplasms View
None Urologic Neoplasms View
None Urogenital Neoplasms View
None Neoplasms by Site View
None Urinary Bladder Diseases View
None Urologic Diseases View
None Mycobacterial cell wall DNA complex View
None Intravesical drug administration View